{"id":8402,"date":"2025-03-16T10:16:00","date_gmt":"2025-03-16T08:16:00","guid":{"rendered":"https:\/\/medilab.km.ua\/?p=8402"},"modified":"2026-06-18T14:43:46","modified_gmt":"2026-06-18T11:43:46","slug":"analysis-of-oncomarkers-methods-of-use-interpretation-of-results","status":"publish","type":"post","link":"https:\/\/medilab.km.ua\/en\/analysis-of-oncomarkers-methods-of-use-interpretation-of-results\/","title":{"rendered":"Cancer marker analysis: methods, applications, interpretation of results"},"content":{"rendered":"<h2 data-start=\"75\" data-end=\"140\"><strong data-start=\"78\" data-end=\"138\">What are tumor markers and how do they help in diagnosis?<\/strong><\/h2>\n<p data-start=\"146\" data-end=\"487\">Tumor markers are specific substances (proteins, antigens, hormones) that are produced by tumor cells or the body in response to the development of the oncological process. Determining the level of these markers in the blood, urine or other biological fluids helps to detect tumors in the early stages, monitor the course of treatment or assess the risk of recurrence.<\/p>\n<p data-start=\"489\" data-end=\"794\">Cancer marker testing is not a stand-alone diagnostic method, but its results can provide important information for the doctor. Since elevated levels of some markers may be associated with inflammatory or benign processes, the diagnosis always requires confirmation by other methods, such as MRI, CT, ultrasound, or biopsy.<\/p>\n<h3 data-start=\"796\" data-end=\"826\"><strong data-start=\"800\" data-end=\"824\">Practical example:<\/strong><\/h3>\n<p data-start=\"827\" data-end=\"1222\">A 45-year-old patient consulted a doctor with complaints of periodic abdominal pain and general fatigue. The gynecologist prescribed a tumor marker test. <strong data-start=\"968\" data-end=\"978\">CA-125<\/strong>, which showed an elevated level of 48 U\/ml (normal \u2013 up to 35 U\/ml). Further ultrasound revealed a cystic formation of the ovary. A biopsy confirmed the benign nature of the tumor, but the woman was recommended dynamic control and regular screening.<\/p>\n<h2 data-start=\"1224\" data-end=\"1280\"><strong data-start=\"1227\" data-end=\"1278\">Indications for tumor marker testing<\/strong><\/h2>\n<p data-start=\"1282\" data-end=\"1334\">A doctor may order testing in the following cases:<\/p>\n<ul data-start=\"1336\" data-end=\"1756\">\n<li data-start=\"1336\" data-end=\"1416\"><strong data-start=\"1338\" data-end=\"1414\">Monitoring patients already undergoing cancer treatment<\/strong><\/li>\n<li data-start=\"1417\" data-end=\"1478\"><strong data-start=\"1419\" data-end=\"1476\">Monitoring for possible recurrence after tumor removal<\/strong><\/li>\n<li data-start=\"1479\" data-end=\"1544\"><strong data-start=\"1481\" data-end=\"1542\">Monitoring the effectiveness of chemotherapy or radiation therapy<\/strong><\/li>\n<li data-start=\"1545\" data-end=\"1601\"><strong data-start=\"1547\" data-end=\"1599\">Risk assessment in people with a family history of cancer<\/strong><\/li>\n<li data-start=\"1602\" data-end=\"1663\"><strong data-start=\"1604\" data-end=\"1661\">Clarification of the diagnosis in case of suspected oncological process<\/strong><\/li>\n<li data-start=\"1664\" data-end=\"1756\"><strong data-start=\"1666\" data-end=\"1754\">Screening in patients with benign tumors that have the potential to become malignant<\/strong><\/li>\n<\/ul>\n<p data-start=\"1758\" data-end=\"1970\">Tumor marker testing can be useful for people who have certain complaints that may indicate a possible cancer process: unexplained weight loss, chronic fatigue, anemia, edema, or changes in the functioning of the digestive organs.<\/p>\n<h2 data-start=\"1506\" data-end=\"1554\"><strong data-start=\"1509\" data-end=\"1552\">Types of tumor markers and their significance<\/strong><\/h2>\n<p data-start=\"1556\" data-end=\"1609\">Each tumor marker is associated with a specific type of tumor.<\/p>\n<div class=\"overflow-x-auto contain-inline-size\">\n<table data-start=\"1611\" data-end=\"2309\">\n<thead data-start=\"1611\" data-end=\"1696\">\n<tr data-start=\"1611\" data-end=\"1696\">\n<th data-start=\"1611\" data-end=\"1628\"><strong data-start=\"1613\" data-end=\"1627\">Tumor marker<\/strong><\/th>\n<th data-start=\"1628\" data-end=\"1668\"><strong data-start=\"1630\" data-end=\"1667\">What diseases can it detect?<\/strong><\/th>\n<th data-start=\"1668\" data-end=\"1696\"><strong data-start=\"1670\" data-end=\"1692\">Normal values<\/strong><\/th>\n<\/tr>\n<\/thead>\n<tbody data-start=\"1770\" data-end=\"2309\">\n<tr data-start=\"1770\" data-end=\"1839\">\n<td><strong data-start=\"1772\" data-end=\"1808\">PSA (prostate-specific antigen)<\/strong><\/td>\n<td>Prostate cancer<\/td>\n<td>&lt; 4 ng\/ml<\/td>\n<\/tr>\n<tr data-start=\"1840\" data-end=\"1897\">\n<td><a href=\"https:\/\/medilab.km.ua\/en\/analysis\/diagnosis-of-tumor-markers\/index-roma-sa-125-he4\/\"><strong data-start=\"1842\" data-end=\"1852\">CA-125<\/strong><\/a><\/td>\n<td>Ovarian cancer, endometriosis<\/td>\n<td>&lt; 35 U\/ml<\/td>\n<\/tr>\n<tr data-start=\"1898\" data-end=\"1973\">\n<td><strong data-start=\"1900\" data-end=\"1911\"><a class=\"wpil_keyword_link\" href=\"https:\/\/medilab.km.ua\/en\/oncomarker-sa-19-9-not-only-for-esophageal-cancer-but-what-does-this-analysis-really-show\/\"   title=\"Tumor marker CA-19-9: not only about pancreatic cancer, or what this analysis really shows\" data-wpil-keyword-link=\"linked\"  data-wpil-monitor-id=\"197\">CA-19-9<\/a><\/strong><\/td>\n<td>Cancer of the pancreas, stomach, intestines<\/td>\n<td>&lt; 37 U\/ml<\/td>\n<\/tr>\n<tr data-start=\"1974\" data-end=\"2026\">\n<td><a href=\"https:\/\/medilab.km.ua\/en\/analysis\/diagnosis-of-tumor-markers\/mammary-gland-oncomarker-sa-15-3\/\"><strong data-start=\"1976\" data-end=\"1987\">CA-15-3<\/strong><\/a><\/td>\n<td>Breast cancer<\/td>\n<td>&lt; 30 U\/ml<\/td>\n<\/tr>\n<tr data-start=\"2027\" data-end=\"2120\">\n<td><strong data-start=\"2029\" data-end=\"2067\">CEA (carcinoembryonic antigen)<\/strong><\/td>\n<td>Colon, stomach, lung cancer<\/td>\n<td>&lt; 5 ng\/ml<\/td>\n<\/tr>\n<tr data-start=\"2121\" data-end=\"2198\">\n<td><a href=\"https:\/\/medilab.km.ua\/en\/analysis\/hormonal-panel\/prenatal-diagnostics\/prenatal-biochemical-screening-2nd-trimester-16-20-weeks\/alpha-fetoprotein-afp-2\/\"><strong data-start=\"2123\" data-end=\"2150\">AFP (alpha-fetoprotein)<\/strong><\/a><\/td>\n<td>Liver, ovarian, testicular cancer<\/td>\n<td>&lt; 10 ng\/ml<\/td>\n<\/tr>\n<tr data-start=\"2199\" data-end=\"2309\">\n<td><strong data-start=\"2201\" data-end=\"2235\">Neuron-specific enolase (NSE)<\/strong><\/td>\n<td>Small cell lung cancer, neuroendocrine tumors<\/td>\n<td>&lt; 16.3 ng\/ml<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p data-start=\"1365\" data-end=\"1646\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-8404\" src=\"https:\/\/medilab.km.ua\/wp-content\/themes\/woodmart\/images\/lazy.svg\" data-src=\"https:\/\/medilab.km.ua\/wp-content\/uploads\/2025\/03\/coronavirus-vaccine-composition-lab.jpg\" alt=\"Laboratory test results for tumor markers\" width=\"1200\" height=\"838\" title=\"\" srcset=\"\" data-srcset=\"https:\/\/medilab.km.ua\/wp-content\/uploads\/2025\/03\/coronavirus-vaccine-composition-lab.jpg 1200w, https:\/\/medilab.km.ua\/wp-content\/uploads\/2025\/03\/coronavirus-vaccine-composition-lab-150x105.jpg 150w, https:\/\/medilab.km.ua\/wp-content\/uploads\/2025\/03\/coronavirus-vaccine-composition-lab-600x419.jpg 600w, https:\/\/medilab.km.ua\/wp-content\/uploads\/2025\/03\/coronavirus-vaccine-composition-lab-300x210.jpg 300w, https:\/\/medilab.km.ua\/wp-content\/uploads\/2025\/03\/coronavirus-vaccine-composition-lab-1024x715.jpg 1024w, https:\/\/medilab.km.ua\/wp-content\/uploads\/2025\/03\/coronavirus-vaccine-composition-lab-768x536.jpg 768w\" sizes=\"auto, (max-width: 1200px) 100vw, 1200px\" \/><\/p>\n<h2 data-start=\"2311\" data-end=\"2362\"><strong data-start=\"2314\" data-end=\"2360\">How to prepare for a tumor marker test<\/strong><\/h2>\n<p data-start=\"2364\" data-end=\"2442\">To ensure that the test results are reliable, the following rules must be followed:<\/p>\n<ul data-start=\"2444\" data-end=\"2777\">\n<li data-start=\"2444\" data-end=\"2480\">do not eat 8-12 hours before the analysis<\/li>\n<li data-start=\"2481\" data-end=\"2537\">the day before the test, exclude alcohol, fatty foods, and coffee<\/li>\n<li data-start=\"2538\" data-end=\"2592\">avoid stress and physical exertion the day before<\/li>\n<li data-start=\"2593\" data-end=\"2631\">Do not smoke 2-3 hours before the analysis.<\/li>\n<li data-start=\"2632\" data-end=\"2699\">It is recommended for women to take the test outside of their menstrual period.<\/li>\n<li data-start=\"2700\" data-end=\"2777\">if a PSA test is performed, sexual intercourse should be avoided for 48 hours<\/li>\n<\/ul>\n<p data-start=\"2779\" data-end=\"2858\">Blood for analysis is taken from a vein, and results are usually ready in 1-2 days.<\/p>\n<h2 data-start=\"3160\" data-end=\"3212\"><strong data-start=\"3163\" data-end=\"3210\">When to take a tumor marker test<\/strong><\/h2>\n<p data-start=\"3214\" data-end=\"3267\">The doctor may prescribe the study in the following cases:<\/p>\n<ul data-start=\"3269\" data-end=\"3500\">\n<li data-start=\"3269\" data-end=\"3312\">If cancer is suspected<\/li>\n<li data-start=\"3313\" data-end=\"3358\">If there is a hereditary predisposition to cancer<\/li>\n<li data-start=\"3359\" data-end=\"3398\">To monitor the effectiveness of treatment<\/li>\n<li data-start=\"3399\" data-end=\"3456\">To monitor condition after surgery or chemotherapy<\/li>\n<li data-start=\"3457\" data-end=\"3500\">To assess the risk of disease recurrence<\/li>\n<\/ul>\n<h2 data-start=\"3458\" data-end=\"3530\"><strong data-start=\"3461\" data-end=\"3528\">Can cancer marker testing be used for prevention?<\/strong><\/h2>\n<p data-start=\"3532\" data-end=\"3795\">Tumor markers are not the main method of preventive diagnostics, but they can be useful in cases of increased risk of developing certain oncological pathologies. For example, men after 50 years of age are recommended to periodically check the PSA level to monitor the condition of the prostate.<\/p>\n<p data-start=\"3797\" data-end=\"3907\">To reduce the risk of cancer, it is important to follow the general rules of a healthy lifestyle:<\/p>\n<ul data-start=\"3909\" data-end=\"4099\">\n<li data-start=\"3909\" data-end=\"3947\">undergo regular medical checkups<\/li>\n<li data-start=\"3948\" data-end=\"3982\">control diet<\/li>\n<li data-start=\"3983\" data-end=\"4011\">avoid bad habits<\/li>\n<li data-start=\"4012\" data-end=\"4047\">maintain physical activity<\/li>\n<li data-start=\"4048\" data-end=\"4099\">pay attention to any unexplained symptoms<\/li>\n<\/ul>\n<h2 data-start=\"3502\" data-end=\"3561\"><strong data-start=\"3505\" data-end=\"3559\">What are the advantages and disadvantages of tumor marker analysis?<\/strong><\/h2>\n<p data-start=\"3563\" data-end=\"3729\">Among the advantages are the safety and non-invasiveness of the method, the ability to detect tumors at an early stage, and its use to monitor the effectiveness of treatment.<\/p>\n<p data-start=\"3731\" data-end=\"3955\">Among the disadvantages is the impossibility of making a diagnosis based solely on tumor markers, since their levels can increase in other diseases, as well as the lack of a universal marker that would detect all types of oncology.<\/p>\n<p data-start=\"3731\" data-end=\"3955\">Tumor marker analysis is an important tool in the diagnosis and monitoring of cancer, but its results cannot be the only basis for making a diagnosis. To confirm or refute oncology, a comprehensive examination is necessary, including additional laboratory, instrumental and clinical diagnostic methods.<\/p>","protected":false},"excerpt":{"rendered":"<p>What are tumor markers and how do they help in diagnosis? Tumor markers are specific substances (proteins, antigens, hormones) that are produced by tumor cells.<\/p>","protected":false},"author":627,"featured_media":8403,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1,236],"tags":[],"class_list":["post-8402","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-zahvoryuvannya-ta-symptomy","category-choloviche-zdorov-ya"],"_links":{"self":[{"href":"https:\/\/medilab.km.ua\/en\/wp-json\/wp\/v2\/posts\/8402","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medilab.km.ua\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medilab.km.ua\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medilab.km.ua\/en\/wp-json\/wp\/v2\/users\/627"}],"replies":[{"embeddable":true,"href":"https:\/\/medilab.km.ua\/en\/wp-json\/wp\/v2\/comments?post=8402"}],"version-history":[{"count":1,"href":"https:\/\/medilab.km.ua\/en\/wp-json\/wp\/v2\/posts\/8402\/revisions"}],"predecessor-version":[{"id":13552,"href":"https:\/\/medilab.km.ua\/en\/wp-json\/wp\/v2\/posts\/8402\/revisions\/13552"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medilab.km.ua\/en\/wp-json\/wp\/v2\/media\/8403"}],"wp:attachment":[{"href":"https:\/\/medilab.km.ua\/en\/wp-json\/wp\/v2\/media?parent=8402"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medilab.km.ua\/en\/wp-json\/wp\/v2\/categories?post=8402"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medilab.km.ua\/en\/wp-json\/wp\/v2\/tags?post=8402"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}